BIOGEN INTERNATIONAL GMBH v. MYLAN PHARMACEUTICALS

2020-1933.

18 F.4th 1333 (2021)

BIOGEN INTERNATIONAL GMBH, Biogen MA, INC., Plaintiffs-Appellants v. MYLAN PHARMACEUTICALS INC., Defendant-Appellee.

United States Court of Appeals, Federal Circuit.

Decided: November 30, 2021.


Attorney(s) appearing for the Case

William F. Lee , Wilmer Cutler Pickering Hale and Dorr LLP, Boston, MA, argued for plaintiffs-appellants. Also represented by Annaleigh E. Curtis , Madeleine C. Laupheimer , Lisa Jon Pirozzolo ; Scott G. Greene , New York, NY; Thomas Saunders , Washington, DC; Paul William Browning , J. Michael Jakes , James B. Monroe , Jason Lee Romrell , Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC.

David Lee Anstaett , Perkins Coie, LLP, Madison, WI, argued for defendant-appellee. Also represented by Andrew Dufresne , Emily Jane Greb ; Dan L. Bagatell , Hanover, NH; Shannon Bloodworth , Nathan K. Kelley , Brandon Michael White , Washington, DC; Matthew Greinert , Mylan, Canonsburg, PA.

Dissenting opinion filed by Circuit Judge O'MALLEY.


This appeal from the United States District Court for the Northern District of West Virginia concerns a patent-infringement dispute between Biogen International GmbH, Biogen MA, Inc., and Mylan Pharmaceuticals, Inc. Biogen owns United States Patent 8,399,514 (the '514 Patent), which claims a method of treating multiple sclerosis...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases